2020 earnings: -25% and falling
AlphaValue’s analysts rushed the earnings-cut exercise as businesses dislocate worldwide with the stay-at-home policy. The amazing thing is that some corporates refuse to see the second order impact of the…
Will banks behave?
Who will be lending? It was clear from late January that the Coronavirus-induced mess was a supply-chain issue and an intercompany credit issue. In China, the true extent of the…
Coronavirus: measuring the temperature of wind OEMs
So far the communication from wind OEMs has been to say that it is too early to measure the consequences of the coronavirus on the business. The full impact will…
Amundi/Sabadell : A relevant agreement
Amundi and Banco Sabadell have announced an agreement whereby Amundi has purchased the Spanish bank’s AM division. They are also entering into a 10-year strategic partnership for the distribution of…
Payment industry: 2020 will be exciting
2019 has been another buoyant year for the payment industry and the fintech industry as a whole. Consolidation or capital raisings have strongly contributed to the headlines while Facebook’s ambition…
Aramco ticks all the red boxes
Saudi Aramco, the giant state-owned oil company, is now listed since 11/12 on the Riyadh’s Tadawul Exchange. With only 1.5% up for sale, the IPO raised a jaw-dropping $25.6bn and…
Looming competition from the east
A number of initiatives taken by the Chinese government to strengthen its pharmaceutical sector have started to bear fruit – Beigene’s ‘zanubrutinib’ became the first innovative drug by a Chinese…
European big pharmas in big numbers
Roche is worth €233bn, only second to Nestlé in the European contest for the largest market caps. The six other big Pharma companies (including Bayer) will bring the total sector…
Française des Jeux : Dear bet
FDJ is a great firm. The French state is charging too high a price for the privilege of accessing a monopoly. The placing syndicate would do well to cut the…
Limitless reinsurers
While we harbour serious worries about the impact of negative rates on the good health of life insurers, we have no such qualms when it comes to Reinsurers. Their high-quality portfolios…
About Us
Founded in 2007, AlphaValue is the world’s leading provider of Independent European Equity and Credit Research. We provide comprehensive, unconflicted research-only (no execution, no corporate finance) coverage of c. 480 European mid and large cap stocks. We have an average of 46% of negative recommendations at any one time. Learn more at www.alphavalue.com
Subscribe Now
Recent Posts
Stellantis is shooting for the stars
Splendid risk taking
Categories
- Activists (24)
- ESG (15)
- Research (87)
- Stocks to Watch (64)
- Uncategorized (2)
- Under Fire (42)
Stay connected